In the US, Wegovy is approved for use in individuals with a BMI over 30 with no other co-morbidities and 27 in individuals with a weight-related condition, such as hypertension
The well established sarcopenia associated with older age seems to be associated in part to a decline in protein and energy intake, caused by changes in taste sensation, alterations in dentition, social isolation, depression and economic factors
That combination is one reason NAD+ and glutathione therapies are often used together in modern wellness and longevity practices
A major role of intracellular GSH is maintaining an optimal redox-potential for normal cellular processes which include activation/inactivation of redox-sensitive proteins, regulation of intracellular pH and potassium, deactivation of toxic substances, and adaptation to various stresses (e.g., oxidative stress, temperature stress, or osmotic stress) [16] [22]
Nonetheless, their use is associated with a high incidence of adverse effects, with reported toxicity rates ranging from 42.8% to 97.3%
